Nutritional Growth Financials
| NGS Stock | 0.04 0.01 10.00% |
Operating Margin (0.87) | Profit Margin (0.99) | Return On Equity (3.05) |
Nutritional | Select Account or Indicator |
Please note, the imprecision that can be found in Nutritional Growth's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nutritional Growth Solutions. Check Nutritional Growth's Beneish M Score to see the likelihood of Nutritional Growth's management manipulating its earnings.
Nutritional Growth Stock Summary
Nutritional Growth competes with Coronado Global. Nutritional Growth is entity of Australia. It is traded as Stock on AU exchange.| Foreign Associate | USA |
Specialization | Consumer Defensive, Food, Beverage & Tobacco |
| Instrument | Australia Stock View All |
| Exchange | Australian Securities Exchange |
| ISIN | IL0011681116 |
| Business Address | 3 Hanechoshet Street, |
| Sector | Food Products |
| Industry | Consumer Staples |
| Benchmark | Dow Jones Industrial |
| Website | ngsolutions.co |
| Phone | 972 1 800 970 4303 |
You should never invest in Nutritional Growth without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Nutritional Stock, because this is throwing your money away. Analyzing the key information contained in Nutritional Growth's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Nutritional Growth Key Financial Ratios
Nutritional Growth's financial ratios allow both analysts and investors to convert raw data from Nutritional Growth's financial statements into concise, actionable information that can be used to evaluate the performance of Nutritional Growth over time and compare it to other companies across industries.| Revenue | 3.06 M | ||||
| Gross Profit | 1.44 M | ||||
| EBITDA | (1.92 M) | ||||
| Net Income | (2.97 M) | ||||
| Cash And Equivalents | 4.14 M |
Nutritional Growth Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 1.2M | 5.2M | 3.4M | 3.0M | 936K | 889.2K | |
| Other Current Liab | 230.5K | 579K | 602.7K | 674.0K | 499.0K | 496.6K | |
| Net Tangible Assets | 613K | 4.2M | 3.8M | 2.0M | 2.3M | 2.8M | |
| Net Debt | (768.2K) | (4.5M) | (2.9M) | (1.5M) | 190K | 199.5K | |
| Retained Earnings | 237.6K | (4.2M) | (6.5M) | (13.2M) | (16.1M) | (15.3M) | |
| Accounts Payable | 49.8K | 186K | 154.4K | 243K | 252K | 218.0K | |
| Cash | 825.1K | 4.6M | 3.0M | 1.5M | 172K | 163.4K | |
| Net Receivables | 93.9K | 278K | 103.7K | 88K | 18K | 17.1K | |
| Inventory | 193.5K | 145K | 229.0K | 1.3M | 681K | 481.8K | |
| Other Current Assets | 71.1K | 200.9K | (1K) | 60K | 18K | 17.1K | |
| Total Liab | 337.2K | 894K | 627.0K | 954.0K | 1.1M | 808.4K | |
| Total Current Assets | 1.2M | 5.1M | 3.3M | 2.9M | 889K | 844.6K | |
| Short Term Debt | 56.9K | 62.2K | 36K | 37K | 351K | 368.6K | |
| Common Stock | 2.8K | 7.8M | 8.0M | 13.4M | 15.9M | 8.3M |
Nutritional Growth Key Income Statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Income | 85K | 140.2K | 47K | 113K | 249K | 132.2K | |
| Interest Expense | 66.2K | 1.7M | 65K | 18K | 48.3K | 45.9K | |
| Total Revenue | 1.7M | 1.4M | 3.0M | 2.9M | 3.1M | 2.4M | |
| Gross Profit | 772.7K | 705.5K | 1.4M | 1.4M | 902.6K | 1.0M | |
| Operating Income | (3.0M) | (1.6M) | (4.7M) | (4.2M) | (3.1M) | (3.2M) | |
| Ebit | (2.9M) | (1.6M) | (4.7M) | (4.3M) | (1.9M) | (2.0M) | |
| Research Development | 369.8K | 183.3K | 897K | 386K | 300.5K | 355.2K | |
| Ebitda | (2.8M) | (1.6M) | (4.7M) | (4.2M) | (1.9M) | (2.0M) | |
| Cost Of Revenue | 931.0K | 728.6K | 1.7M | 1.5M | 2.2M | 1.4M | |
| Income Before Tax | (2.9M) | (3.3M) | (4.8M) | (4.2M) | (3.0M) | (3.1M) | |
| Net Income | (2.9M) | (3.3M) | (4.8M) | (4.2M) | (2.0M) | (2.1M) | |
| Income Tax Expense | 5.8K | 766.89 | (146.6K) | (227.5K) | (71.5K) | (75.0K) |
Nutritional Growth Key Cash Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (92.1K) | (10.0K) | (164.2K) | (1.4M) | 573.4K | 602.0K | |
| Change In Cash | (2.6M) | 3.1M | (353.7K) | (2.6M) | (1.3M) | (1.3M) | |
| Free Cash Flow | (2.6M) | (1.8M) | (3.7M) | (7.0M) | (2.3M) | (2.5M) | |
| Depreciation | 13.0K | 11.1K | 106.2K | 88.0K | 96.4K | 57.9K | |
| Other Non Cash Items | 674.9K | 2.8M | 874.9K | 305.8K | 560.0K | 927.0K | |
| Capital Expenditures | 21.6K | 61.4K | 57.3K | 4K | 2.38 | 2.26 | |
| Net Income | (2.9M) | (4.9M) | (4.6M) | (6.1M) | (3.0M) | (3.1M) | |
| End Period Cash Flow | 825.1K | 3.6M | 3.0M | 1.5M | 172K | 163.4K | |
| Change To Netincome | 325K | 2.5M | 906K | 216K | 248.4K | 236.0K |
Nutritional Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nutritional Growth's current stock value. Our valuation model uses many indicators to compare Nutritional Growth value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nutritional Growth competition to find correlations between indicators driving Nutritional Growth's intrinsic value. More Info.Nutritional Growth Solutions is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nutritional Growth's earnings, one of the primary drivers of an investment's value.Nutritional Growth Systematic Risk
Nutritional Growth's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nutritional Growth volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Nutritional Growth correlated with the market. If Beta is less than 0 Nutritional Growth generally moves in the opposite direction as compared to the market. If Nutritional Growth Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nutritional Growth is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nutritional Growth is generally in the same direction as the market. If Beta > 1 Nutritional Growth moves generally in the same direction as, but more than the movement of the benchmark.
Nutritional Growth Solutions Total Assets Over Time
Nutritional Growth December 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Nutritional Growth help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nutritional Growth Solutions. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nutritional Growth Solutions based on widely used predictive technical indicators. In general, we focus on analyzing Nutritional Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nutritional Growth's daily price indicators and compare them against related drivers.
| Downside Deviation | 8.66 | |||
| Information Ratio | 0.1297 | |||
| Maximum Drawdown | 56.06 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 16.13 |
Additional Tools for Nutritional Stock Analysis
When running Nutritional Growth's price analysis, check to measure Nutritional Growth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutritional Growth is operating at the current time. Most of Nutritional Growth's value examination focuses on studying past and present price action to predict the probability of Nutritional Growth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutritional Growth's price. Additionally, you may evaluate how the addition of Nutritional Growth to your portfolios can decrease your overall portfolio volatility.